Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS).


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Aug 2021
Historique:
received: 02 06 2021
revised: 20 07 2021
accepted: 10 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 18 9 2021
Statut: epublish

Résumé

Dysphagia is a highly prevalent symptom in Amyotrophic Lateral Sclerosis (ALS), and the implantation of a percutaneous endoscopic gastrostomy (PEG) is a very frequent event. The aim of this study was to evaluate the influence of PEG implantation on survival and complications in ALS. An interhospital registry of patients with ALS of six hospitals in the Castilla-León region (Spain) was created between January 2015 and December 2017. The data were compared for those in whom a PEG was implanted and those who it was not. A total of 93 patients were analyzed. The mean age of the patients was 64.63 (17.67) years. A total of 38 patients (38.8%) had a PEG implantation. An improvement in the anthropometric parameters was observed among patients who had a PEG from the beginning of nutritional follow-up compared to those who did not, both in BMI (kg/m

Identifiants

pubmed: 34444925
pii: nu13082765
doi: 10.3390/nu13082765
pmc: PMC8401888
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Gerencia de Salud de Castilla y León
ID : GRS 1238/A/16
Organisme : Sociedad Castellano-Leonesa de Endocrinología, Diabetes y Nutrición
ID : Beca SCLEDyN 2017-2018

Références

Amyotroph Lateral Scler. 2011 May;12(3):206-9
pubmed: 21506897
Amyotroph Lateral Scler. 2012 Oct;13(6):555-9
pubmed: 22871077
BMC Neurol. 2013 Jul 12;13:84
pubmed: 23848967
Clin Nutr. 2015 Oct;34(5):785-92
pubmed: 25596153
Amyotroph Lateral Scler. 2012 Oct;13(6):550-4
pubmed: 22708872
J Neurol Sci. 2001 Oct 15;191(1-2):3-9
pubmed: 11676986
Minerva Gastroenterol Dietol. 2012 Sep;58(3):253-60
pubmed: 22971635
Muscle Nerve. 2016 Aug;54(2):277-83
pubmed: 26799526
J Neurol Sci. 2017 May 15;376:202-205
pubmed: 28431613
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):515-521
pubmed: 27534658
Arq Neuropsiquiatr. 2014 Feb;72(2):157-63
pubmed: 24604371
Nutr Hosp. 2014 Dec 01;30(6):1289-94
pubmed: 25433110
ESPEN J. 2013 Feb 1;8(1):e25-e28
pubmed: 25568837
Nutrition. 2018 Apr;48:67-72
pubmed: 29469023
J Neurol. 2015;262(4):849-58
pubmed: 25618254
Clin Nutr. 2021 Jan;40(1):237-244
pubmed: 32507583
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Eur J Neurol. 2012 Mar;19(3):360-75
pubmed: 21914052
MMWR Morb Mortal Wkly Rep. 2018 Nov 23;67(46):1285-1289
pubmed: 30462626
Amyotroph Lateral Scler. 2012 May;13(3):318-25
pubmed: 22533463
Respir Care. 2013 May;58(5):838-44
pubmed: 23107129
Lancet Neurol. 2015 Jul;14(7):702-9
pubmed: 26027943
Nutr Hosp. 2016 Sep 20;33(5):561
pubmed: 27759965
Nutr Hosp. 2013 Nov 01;28(6):2014-20
pubmed: 24506382
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):528-32
pubmed: 23886339
Clin Nutr. 2018 Feb;37(1):354-396
pubmed: 29274834
Nutr Hosp. 2015 May 07;31 Suppl 5:56-66
pubmed: 25938606
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90
pubmed: 19710046
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23
pubmed: 19922118
Neurologia (Engl Ed). 2019 Nov - Dec;34(9):582-588
pubmed: 29599075

Auteurs

Juan J López-Gómez (JJ)

Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Centro de Investigación Endocrinología y Nutrición de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.

María D Ballesteros-Pomar (MD)

Centro de Investigación Endocrinología y Nutrición de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.
Sección de Endocrinología y Nutrición, Complejo Asistencial Universitario de León, 24008 León, Spain.

Beatriz Torres-Torres (B)

Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Centro de Investigación Endocrinología y Nutrición de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.

Begoña Pintor-De la Maza (B)

Sección de Endocrinología y Nutrición, Complejo Asistencial Universitario de León, 24008 León, Spain.

María A Penacho-Lázaro (MA)

Servicio de Endocrinología y Nutrición, Hospital de El Bierzo, 24404 Ponferrada, Spain.

José M Palacio-Mures (JM)

Servicio de Endocrinología y Nutrición, Hospital Universitario Rio Hortega, 47012 Valladolid, Spain.

Cristina Abreu-Padín (C)

Servicio de Endocrinología y Nutrición, Complejo Asistencial de Segovia, 40002 Segovia, Spain.

Irene Sanz-Gallego (I)

Servicio de Neurología, Complejo Asistencial de Ávila, 05071 Ávila, Spain.

Daniel A De Luis-Román (DA)

Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Centro de Investigación Endocrinología y Nutrición de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH